Marker Therapeutics Inc (MRKR) — Financial Flexibility Index
Marker Therapeutics Inc (MRKR) has a Financial Flexibility Index of -0.82x as of September 2025. Free cash flow of $-2.74 Million (operating CF $-2.74 Million minus capex $4.00) represents -1% of total liabilities ($3.35 Million). Also explore MRKR year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Marker Therapeutics Inc Financial Flexibility Index (1999–2024)
Historical Financial Flexibility Index trend for Marker Therapeutics Inc across 26 annual periods. Check MRKR strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Marker Therapeutics Inc (1999–2024)
Year-by-year free cash flow to debt coverage for Marker Therapeutics Inc. For the full company profile including market capitalisation, see MRKR market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.15x | $-10.91 Million | $-10.91 Million | $3.46 Million | ▲ +41.1% |
| 2023 | -5.35x | $-16.44 Million | $-16.44 Million | $3.07 Million | ▼ -193.8% |
| 2022 | -1.82x | $-26.97 Million | $-26.97 Million | $14.82 Million | ▼ -82.0% |
| 2021 | -1.00x | $-24.15 Million | $-27.28 Million | $24.15 Million | ▼ -69.4% |
| 2020 | -0.59x | $-10.78 Million | $-20.03 Million | $18.27 Million | ▲ +92.5% |
| 2019 | -7.88x | $-17.91 Million | $-18.28 Million | $2.27 Million | ▼ -54.1% |
| 2018 | -5.11x | $-14.33 Million | $-14.48 Million | $2.80 Million | ▲ +6.1% |
| 2017 | -5.45x | $-8.29 Million | $-8.44 Million | $1.52 Million | ▼ -48.7% |
| 2016 | -3.66x | $-6.36 Million | $-6.51 Million | $1.74 Million | ▼ -2345.1% |
| 2015 | -0.15x | $-4.20 Million | $-4.34 Million | $28.01 Million | ▲ +91.5% |
| 2014 | -1.75x | $-2.19 Million | $-2.19 Million | $1.25 Million | ▼ -2131.6% |
| 2013 | -0.08x | $-694.58K | $-694.58K | $8.85 Million | ▲ +71.0% |
| 2012 | -0.27x | $-1.57 Million | $-1.57 Million | $5.77 Million | ▲ +21.3% |
| 2011 | -0.34x | $-1.31 Million | $-1.31 Million | $3.80 Million | ▼ -26.3% |
| 2010 | -0.27x | $-925.04K | $-925.04K | $3.39 Million | ▲ +76.0% |
| 2009 | -1.14x | $-1.12 Million | $-1.12 Million | $986.35K | ▼ -405.6% |
| 2008 | -0.22x | $-692.00K | $-714.42K | $3.08 Million | ▲ +63.5% |
| 2007 | -0.62x | $-1.20 Million | $-1.23 Million | $1.95 Million | ▼ -63.8% |
| 2006 | -0.38x | $-1.19 Million | $-1.19 Million | $3.15 Million | ▲ +25.3% |
| 2005 | -0.50x | $-1.16 Million | $-1.16 Million | $2.31 Million | ▼ -4.8% |
| 2004 | -0.48x | $-1.21 Million | $-1.21 Million | $2.53 Million | ▲ +86.3% |
| 2003 | -3.51x | $-2.59 Million | $-2.59 Million | $736.95K | ▲ +25.9% |
| 2002 | -4.74x | $-1.40 Million | $-1.41 Million | $295.60K | ▼ -34597.9% |
| 2001 | 0.01x | $2.38K | $2.38K | $173.03K | ▲ +101.1% |
| 2000 | -1.28x | $-876.88K | $-879.74K | $682.74K | ▲ +51.1% |
| 1999 | -2.63x | $-761.15K | $-815.18K | $289.71K | — |